James Knight
Corporate Officer/Principal at SYNACT PHARMA AB
Net worth: 50 077 $ as of 2024-05-30
Network origin in James Knight first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.
48
| Subsidiary | Pharmaceuticals: Major | 48 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Medical/Nursing Services | 14 | |
| Subsidiary | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to James Knight via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal Director/Board Member Comptroller/Controller/Auditor Director/Board Member | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chairman General Counsel Director/Board Member Director/Board Member Compliance Officer | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Chief Executive Officer Director of Finance/CFO | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Human Resources Officer General Counsel | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer Sales & Marketing | |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal President President Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Chairman | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Wisconsin | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| TXP Pharma GmbH | Founder Chief Executive Officer Founder Founder | ||
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer Director/Board Member Human Resources Officer | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member General Counsel | |
| University of Lund | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Sales & Marketing | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| SHIRE | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| The California State University | College/University | Undergraduate Degree Undergraduate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| KINDRED BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Haas School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| TALPHERA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree | |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| OTONOMY | Biotechnology | Director/Board Member Compliance Officer | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member General Counsel |
Statistics
International
| United States | 39 |
| Ireland | 5 |
| Denmark | 4 |
| Sweden | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Finance | 2 |
Operational
| Director/Board Member | 285 |
| Corporate Officer/Principal | 190 |
| Chief Executive Officer | 85 |
| Independent Dir/Board Member | 77 |
| Chief Tech/Sci/R&D Officer | 71 |
Most connected contacts
| Insiders | |
|---|---|
| George Golumbeski | 36 |
| Torbjørn Bjerke | 27 |
| Jeppe Øvlesen | 27 |
| Todd Davis | 23 |
| Lars Ekman | 21 |
| Björn Westberg | 21 |
| George Martin | 21 |
| Uli Alf Hacksell | 20 |
| Terje Kalland | 20 |
| Brian Kotzin | 20 |
| Nancy Lurker | 20 |
| Scott Whitcup | 18 |
| Richard H. Chin | 17 |
| Nils Thomas von Koch | 17 |
| Shalini Sharp | 17 |
- Stock Market
- Insiders
- James Knight
- Company connections
